Altium Capital Management LLC / RARE
Altium Capital Management LLC’s Ultragenyx Pharmaceutical In Position
Does Altium Capital Management LLC own Ultragenyx Pharmaceutical In (RARE)? Not currently — the last reported position was 70.0K shares worth $3M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q2 2024
Shares
70.0K
% of Portfolio
+1.17%
Quarters Held
1
position exited
Position History RARE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 70.0K | $3M | +1.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of RARE.